T. Sticz

Characteristic mTOR activity in Hodgkin-lymphomas offers a potential therapeutic target in high risk disease – a combined tissue microarray, in vitro and in vivo study

Ágnes Márk, Melinda Hajdú, Zsófia Váradi et al. · BMC Cancer · 2013 · 39 citations · Full text

Mammalian Target of Rapamycin (mTOR) Activity Dependent Phospho-Protein Expression in Childhood Acute Lymphoblastic Leukemia (ALL)

Karolina Nemes, Anna Sebestyén, Ágnes Márk et al. · PLoS ONE · 2013 · 27 citations · Full text

Mixed-phenotype Acute Leukemia, Immunology, Increased Mtor Activity +16

Activity and complexes of mTOR in diffuse large B-cell lymphomas—a tissue microarray study

Anna Sebestyén, T. Sticz, Ágnes Márk et al. · Modern Pathology · 2012 · 24 citations · Full text

Hematological Malignancy, Tumor Biology, Lymphoid Neoplasia +6

mTOR activity and its prognostic significance in human colorectal carcinoma depending on C1 and C2 complex-related protein expression

T. Sticz, Anna Molnár, Ágnes Márk et al. · Journal of Clinical Pathology · 2016 · 20 citations

mTOR Pathway As a Potential Target In a Subset of Human Medulloblastoma

Tímea Pócza, Anna Sebestyén, Eszter Turányi et al. · Pathology & Oncology Research · 2014 · 13 citations

Neuro-oncology, Human Medulloblastoma, Medicine +6